Publication & Citation Trends
Most Cited Works
Publications
1,122 total
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer PDF
Cited by 376
OpenAlex
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study PDF
Cited by 544
OpenAlex
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer PDF
Cited by 427
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(448)
Lung Cancer Research Studies
(260)
Cancer Genomics and Diagnostics
(194)
Lung Cancer Diagnosis and Treatment
(177)
Radiomics and Machine Learning in Medical Imaging
(108)
Frequent Co-Authors
Affiliations
AstraZeneca (United Kingdom)
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
University of Maryland, Baltimore
Indiana University Health